JP2023536961A5 - - Google Patents
Info
- Publication number
- JP2023536961A5 JP2023536961A5 JP2023507727A JP2023507727A JP2023536961A5 JP 2023536961 A5 JP2023536961 A5 JP 2023536961A5 JP 2023507727 A JP2023507727 A JP 2023507727A JP 2023507727 A JP2023507727 A JP 2023507727A JP 2023536961 A5 JP2023536961 A5 JP 2023536961A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- agent
- drug
- cancer cells
- spacer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062053P | 2020-08-06 | 2020-08-06 | |
| PCT/US2021/053867 WO2022032244A2 (en) | 2020-08-06 | 2021-10-06 | Methods and agents for the detection and treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536961A JP2023536961A (ja) | 2023-08-30 |
| JP2023536961A5 true JP2023536961A5 (https=) | 2024-10-10 |
Family
ID=80120138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507727A Pending JP2023536961A (ja) | 2020-08-06 | 2021-10-06 | 癌の検出および処置のための方法および薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230285606A1 (https=) |
| EP (1) | EP4192584A4 (https=) |
| JP (1) | JP2023536961A (https=) |
| KR (1) | KR20240066128A (https=) |
| CN (1) | CN116406279B (https=) |
| AU (1) | AU2021320495A1 (https=) |
| CA (1) | CA3188422A1 (https=) |
| WO (1) | WO2022032244A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010019884A1 (en) * | 2008-08-14 | 2010-02-18 | Case Western Reserve University | Methods and compositions for the detection of cancer |
| WO2025250644A1 (en) * | 2024-05-28 | 2025-12-04 | Case Western Reserve University | Fluorescent nuclide-containing agents for detecting and treating cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9415122B2 (en) * | 2008-08-14 | 2016-08-16 | Case Western Reserve University | Methods and compositions for the detection of cancer cells |
| WO2010019884A1 (en) * | 2008-08-14 | 2010-02-18 | Case Western Reserve University | Methods and compositions for the detection of cancer |
| US10632179B2 (en) * | 2013-01-11 | 2020-04-28 | Case Western Reserve University | Methods and compositions for treating cancer |
| US20210100920A1 (en) * | 2017-04-24 | 2021-04-08 | Case Western Reserve University | Methods and agents for the detection and treatment of cancer |
| CA3100349A1 (en) * | 2018-05-17 | 2019-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Receptor inhibition by phosphatase recruitment |
-
2021
- 2021-10-06 WO PCT/US2021/053867 patent/WO2022032244A2/en not_active Ceased
- 2021-10-06 CA CA3188422A patent/CA3188422A1/en active Pending
- 2021-10-06 KR KR1020237007227A patent/KR20240066128A/ko active Pending
- 2021-10-06 EP EP21853122.6A patent/EP4192584A4/en active Pending
- 2021-10-06 CN CN202180068521.9A patent/CN116406279B/zh active Active
- 2021-10-06 AU AU2021320495A patent/AU2021320495A1/en active Pending
- 2021-10-06 JP JP2023507727A patent/JP2023536961A/ja active Pending
- 2021-10-06 US US18/019,993 patent/US20230285606A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3071595B1 (en) | Humanised anti kallikrein-2 antibody | |
| JP2013532126A5 (https=) | ||
| CA2989489A1 (en) | Cellular targeted label delivery system | |
| Natarajan et al. | Development of multivalent radioimmunonanoparticles for cancer imaging and therapy | |
| JP2005523687A5 (https=) | ||
| JP2023536961A5 (https=) | ||
| JP2010017189A5 (https=) | ||
| CN115379848A (zh) | 靶向间充质干细胞衍生的癌细胞和间充质干细胞相关疾病的免疫治疗诊断剂 | |
| CN102056591A (zh) | 脂质体药剂及其制备方法和用途 | |
| JP5966000B2 (ja) | 腫瘍ターゲティング腫瘍壊死因子関連アポトーシス誘導リガンド変異体及びその応用 | |
| JP2020524141A5 (https=) | ||
| Yoo et al. | Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy | |
| CN117327182A (zh) | Cldn18.2单域抗体探针的制备方法及应用 | |
| Wang et al. | Design, preclinical evaluation, and first-in-human PET study of [68Ga] Ga-PSFA-01: a PSMA/FAP heterobivalent tracer | |
| Wu et al. | Expanding horizons in theragnostics: from oncology to multidisciplinary applications | |
| CN107556367A (zh) | 一种肿瘤免疫治疗预测生物标志物pd‑l2靶向多肽及其应用 | |
| WO2023179789A1 (zh) | 干扰趋化素样因子超家族成员6(cmtm6)表达的基因治疗载体的制备和抗肿瘤应用 | |
| US10202432B2 (en) | Dual targeting drug carrier and application thereof | |
| JP2022517662A (ja) | 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドｐｅｔ／ｓｐｅｃｔプローブ | |
| US8101157B2 (en) | Ligands to radiation-induced molecules | |
| Liu et al. | Dual-targeted molecular probes for cancer imaging | |
| AU2016334715B2 (en) | Humanized anti PSA (5A10) antibodies | |
| CN116925189A (zh) | 一种新型靶向肿瘤PD-L1的探针99mTc标记亲合体的制备 | |
| GB2437727A (en) | Aptamers against MUC1 and their uses | |
| JP2022535816A5 (https=) |